The translation regulatory subunit eiF3f controls the kinase-dependent mTOR signaling required for muscle differentiation and hypertrophy in mouse

83Citations
Citations of this article
115Readers
Mendeley users who have this article in their library.

Abstract

The mTORC1 pathway is required for both the terminal muscle differentiation and hypertrophy by controlling the mammalian translational machinery via phosphorylation of S6K1 and 4E-BP1. mTOR and S6K1 are connected by interacting with the eIF3 initiation complex. The regulatory subunit eIF3f plays a major role in muscle hypertrophy and is a key target that accounts for MAFbx function during atrophy. Here we present evidence that in MAFbx-induced atrophy the degradation of eIF3f suppresses S6K1 activation by mTOR, whereas an eIF3f mutant insensitive to MAFbx polyubiquitination maintained persistent phosphorylation of S6K1 and rpS6. During terminal muscle differentiation a conserved TOS motif in eIF3f connects mTOR/raptor complex, which phosphorylates S6K1 and regulates downstream effectors of mTOR and Cap-dependent translation initiation. Thus eIF3f plays a major role for proper activity of mTORC1 to regulate skeletal muscle size. © 2010 Csibi et al.

Cite

CITATION STYLE

APA

Csibi, A., Cornille, K., Leibovitch, M. P., Poupon, A., Tintignac, L. A., Sanchez, A. M. J., & Leibovitch, S. A. (2010). The translation regulatory subunit eiF3f controls the kinase-dependent mTOR signaling required for muscle differentiation and hypertrophy in mouse. PLoS ONE, 5(2). https://doi.org/10.1371/journal.pone.0008994

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free